Sorcero Fall 2026 turns Medical Affairs AI into one governed platform

Sorcero said its Fall 2026 release expands Sorcero Medical™ into a single governed AI and data platform for every medical-affairs team, adding Medical Strategy stakeholder-alignment scoring, executive-grade pipeline analytics, and named solutions for Field Medical through Medical Communications. The release is available now to Sorcero Medical customers (PR Newswire). Sorcero Wizard conversational AI is entering beta for current customers by month-end — not GA.

HEALTH desk — same-day company primary that a medical-affairs AI vendor is shipping a governed platform release customers can use now, with strategy scoring and executive observability — not another generic chatbot wrap.

Pitch, as the same wire has it: the release positions Sorcero Medical as one governed AI and data platform. Individual teams can adopt purpose-built tools as they need them, while the enterprise keeps centralized governance across the medical organization. File that one-platform / purpose-built-per-team / central-governance picture as Sorcero’s. This desk did not sit with a medical-affairs team.

New Medical Strategy solution, still company: teams can encode Strategic Imperatives — the objectives the medical organization is accountable for — into the platform. Sorcero then scores how each stakeholder in that universe, including KOLs and HCPs, aligns to those imperatives as part of a Therapy Resonance Profile that tracks scientific sentiment alongside scientific alignment. A KOL is a key opinion leader, an influential clinician. An HCP is a healthcare professional — a doctor, nurse, or other clinician. The company says the scores are continuous, longitudinal, and evidence-backed, so a leader sees not only where a stakeholder stands but how that position is moving. File that scoring picture as Sorcero’s. This desk did not score a stakeholder.

New executive-grade analytics, company: a customer-facing analytics interface, dashboards, and scheduled email updates give medical IT and operations leaders visibility into the platform’s own operation — data ingestion, transformation, enrichment, and intelligence generation across every connected source. File that pipeline-observability picture as Sorcero’s. This desk did not open a dashboard.

Named team solutions listed on the same wire, company: Field Medical (pre-call planning, stakeholder profiles, scientific-sentiment capture, and MSL-note structuring, with the Sorcero Capture App on iPad and now on iPhone); Field Medical Excellence; Medical Strategy and Impact; Medical Intelligence & Analytics; Medical Information; Medical Communications; and Therapeutic Leadership & Launch. An MSL is a medical science liaison — the field scientist who meets doctors. Aligned suites on the same backbone: Access (beta), Safety, and SciComms. File those names as Sorcero’s. This desk is not inventing extra branded suites beyond what the wire printed.

Availability, company: the Fall 2026 release is available now to Sorcero Medical customers. File that available-now line from the PR Newswire. This desk did not open a customer account. The release does not print a price. This desk is not inventing one.

Sorcero Wizard, still company and not generally available: a multi-turn conversational layer that holds context across an exchange, entering beta for current customers by the end of the month. The company claims guardrails including prohibited-intent detection and source traceability. Beta means limited or preview access — not a claim that Wizard is generally available. Do not file Wizard as GA. File that beta / guardrails / source-traceability picture as Sorcero’s. This desk did not chat with Wizard.

Compliance claims, company — attribute, do not independently certify: Sorcero says it maintains SOC II Type 2, GxP, GPP, 21 CFR Part 11, GDPR, and Data Privacy Framework compliance, which the company says are independently audited. SOC II Type 2 is an audit of how a vendor handles customer data over time. GxP is the family of good-practice rules used in life-science manufacturing and labs. GPP is good publication practice for medical papers. 21 CFR Part 11 is the U.S. FDA rule for electronic records and signatures. GDPR is the EU’s data-privacy law. File those badges as Sorcero’s. This desk did not review an audit letter.

Accuracy and time claims, still company marketing — attribute, do not verify independently: the about-box says Sorcero’s medically tuned AI is more than 96% accurate and reduces scientific data analysis time by more than 72%. The company product page also says Sorcero works with 40% of the Top 30 Global Pharma companies. File the more-than-96%, more-than-72%, and 40% lines as Sorcero’s. This desk did not rerun those numbers or audit a customer roll. This desk is not inventing named customer logos beyond that company share claim.

Named voice on the release: Dipanwita Das, chief executive and co-founder of Sorcero. She says medical affairs was sold general-purpose AI and told to make it fit, and that the problem was never intelligence — it was specificity. File the name, title, and that specificity line as hers, via Sorcero. Her other quotes are color only and stay in Sources.

Plain English for the rest of the card: medical affairs = the scientific and medical teams at a drug company who talk with doctors and track evidence, not sales. KOL = key opinion leader, an influential clinician. HCP = healthcare professional. MSL = medical science liaison, the field scientist who meets doctors. Strategic Imperatives = the objectives the medical organization is accountable for. Therapy Resonance Profile = Sorcero’s name for a live read of stakeholder sentiment and alignment. GA = generally available, shipping widely. beta = limited or preview access, not GA. SOC II Type 2 = an audit of how a vendor handles customer data over time.

PRIMARY here: Sorcero’s 15 Sep 2026 PR Newswire company release — Tier A PRIMARY company source, the original record. The sorcero.com/product/medical page is product-home context, not a second originating newsroom. The Fall 2026 release, the most-significant-expansion line, the one-governed-platform / purpose-built-per-team picture, Medical Strategy scoring and Therapy Resonance Profiles, the executive analytics layer, the named Field Medical through Therapeutic Leadership solutions plus Access / Safety / SciComms suites, the available-now-to-customers line, Sorcero Wizard entering beta by month-end — not GA — the SOC II Type 2 / GxP / GPP / 21 CFR Part 11 / GDPR / Data Privacy Framework badges, the more-than-96% / more-than-72% accuracy and time claims, the 40% of Top 30 Global Pharma share claim, and the Das name are company-attributed. Accuracy, time-saved, customer-share, and compliance badges stay company-attributed — not independently verified here. NOT claimed: pricing, that Wizard is generally available, independently verified accuracy or time-saved figures, named customer logos beyond the company 40% share claim, that this desk tested Sorcero Medical, a stock tip, or investment advice. Distinct from the already-filed latent-health-60-systems, knowtex-frontier-ai-lab, hello-patient-acquires-converse, kairon-health-5m, mgi-visiomics-europe, and openevidence-penn-medicine.